Search Results - "Meyer, Wally"

Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735 by JONES, Stephen, HOLMES, Frankie Ann, HYMAN, William J, RICHARDS, Donald A, MENNEL, Robert G, BOEHM, Kristi A, MEYER, Wally G, ASMAR, Lina, MACKEY, Daniel, RIEDEL, Stefan, MUSS, Hyman, SAVIN, Michael A, O'SHAUGHNESSY, Joyce, BLUM, Joanne L, VUKELJA, Svetislava J, MCINTYRE, Kristi J, PIPPEN, John E, BORDELON, James H, KIRBY, Robert L, SANDBACH, John

“…We previously reported that four cycles of docetaxel/cyclophosphamide (TC) produced superior disease-free survival (DFS) compared with four cycles of…”
Get full text

The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer by Osborne, Cynthia R., Duncan, Anita, Sedlacek, Scot, Paul, Devchand, Holmes, Frankie, Vukelja, Svetislava, Kasper, Michael, Wilks, Sharon, Schneider, Andrew, McGee, Richard, Meyer, Wally G., O’Shaughnessy, Joyce A.

“…Tamoxifen significantly reduces the risk of developing breast cancer in women at increased-risk. The usefulness of tamoxifen has been limited by its side…”
Get full text

Phase I trial of interferon gamma retroviral vector administered intratumorally with multiple courses in patients with metastatic melanoma by Nemunaitis, J, Fong, T, Burrows, F, Bruce, J, Peters, G, Ognoskie, N, Meyer, W, Wynne, D, Kerr, R, Pippen, J, Oldham, F, Ando, D

“…The purpose of this study was to determine the safety and antitumor activity of IFN-gamma retroviral vector in patients with advanced melanoma. Seventeen…”
Get more information

Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation by Benyunes, M C, Sullivan, K M, Deeg, H J, Mori, M, Meyer, W, Fisher, L, Bensinger, R, Jack, M K, Hicks, J, Witherspoon, R

“…To determine the risk of, and risk factors for, developing cataracts after bone marrow transplantation. Four hundred and ninety-two adults who underwent bone…”
Get more information

Irinotecan hydrochloride (CPT-11) resistance identified by K-ras mutation in patients with progressive colon cancer after treatment with 5-fluorouracil (5-FU) by NEMUNAITIS, J, COX, J, MEYER, W, COURTNEY, A, MUES, G

“…To determine the prognostic role of a K-ras mutation in tumor tissue of patients with refractory colon cancer who received irinotecan hydrochloride (CPT-11)…”
Get full text

Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma by Nemunaitis, J, Bohart, C, Fong, T, Meyer, W, Edelman, G, Paulson, R S, Orr, D, Jain, V, O'Brien, J, Kuhn, J, Kowal, K J, Burkeholder, S, Bruce, J, Ognoskie, N, Wynne, D, Martineau, D, Ando, D

“…The purpose of this study was to determine the safety of treating melanoma patients with retroviral vector-mediated interferon (IFN)-gamma gene-transduced…”
Get more information

Improved survival in patients with advanced colorectal carcinoma failing 5-fluorouracil who received irinotecan hydrochloride and have high intratumor C-fos expression by SINGH, A, TONG, A, OGNOSKIE, N, MEYER, W, NEMUNAITIS, J

“…This study determines the prognostic role of c-fos protein expression in patients with colon cancer who previously failed therapy with 5-fluorouracil (5-FU)…”
Get full text

Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia by Nemunaitis, J, Appelbaum, FR, Lilleby, K, Buhles, WC, Rosenfeld, C, Zeigler, ZR, Shadduck, RK, Singer, JW, Meyer, W, Buckner, CD

“…A phase I trial was conducted with recombinant human interleukin-1 beta (rhIL-1 beta) in patients undergoing autologous bone marrow (BM) transplantation for…”
Get full text

Prognostic Role of K-ras in Patients with Progressive Colon Cancer Who Received Treatment with Marimastat (BB2516) by Nemunaitis, John, Cox, John, Hays, Sarah, Meyer, Wally, Kebart, Richard, Ognoskie, Nadine, Courtney, Alice, Yu, Yaang, Rasmussen, Henrick, Tong, Alex

“…Abstract We determined the prognostic role of K-ras mutation in tumor tissue of patients with refractory colon cancer who received Marimastat (BB2516). DNA was…”
Get full text

Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy : A phase II trial by NEMUNAITIS, J, COX, J, MEYER, W, COURTNEY, A, HANSON, T, GREEN-WEAVER, C, AGOSTI, J

“…Functional effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human granulocyte-macrophage colony-stimulating factor…”
Get full text

Pentoxifylline and ciprofloxacin in patients with myelodysplastic syndrome. A phase II trial by Nemunaitis, J, Rosenfeld, C, Getty, L, Boegel, F, Meyer, W, Jennings, L W, Zeigler, Z, Shadduck, R

“…Tumor necrosis factor (TNF) inhibits hematopoietic cell proliferation. The combination of pentoxifylline (PTX) and ciprofloxacin (Cipro) has been previously…”
Get more information

Infection of elderly patients receiving high dose cytarabine-based chemotherapy for induction treatment of acute myelogenous leukemia (AML) by Nemunaitis, J, Meyer, W, Taylor, E, Riley, C, Cooper, B

Get more information

Phase I Study of Recombinant Interleukin-1β in Patients Undergoing Autologous Bone Marrow Transplant for Acute Myelogenous Leukemia by Nemunaitis, John, Appelbaum, Frederick R., Lilleby, Kathy, Buhles, William C., Rosenfeld, Craig, Zeigler, Zella R., Shadduck, Richard K., Singer, Jack W., Meyer, Wally, Buckner, C.Dean

“…A phase I trial was conducted with recombinant human interleukin-1β (rhIL-1β) in patients undergoing autologous bone marrow (BM) transplantation for acute…”
Get full text

AIDS and class II microbiological safety cabinets by Wallbank, A M, Meyer, W

Get full text

Immunofluorescence of peritoneal phagocytes after infection in vivo with egg-attenuated Chlamydia psittaci 6BC by Kordová, N, Martin, C, Wilt, J C, Meyer, W

Get more information

Immunofluorescence of peritoneal phagocytes after infection of mice with L-cell-attenuated Chlamydia psittaci 6BC by Kordova, N, Wilt, J C, Shewchuk, E, Meyer, W

“…Large amounts of particulate antigen of Chlamydia psittaci 6BC attenuated by growth in L cells were phagocytized by peritoneal mononuclear phagocytes during…”
Get more information